Results 191 to 200 of about 145,985 (243)
Hematoxylin and Eosin Staining Helps Reduce Maternal Contamination in Short Tandem Repeat Genotyping for Hydatidiform Mole Diagnosis. [PDF]
Zhao Y+7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biallelic NLRP7 variants in patients with recurrent hydatidiform mole: A review and expert consensus
Human Mutation, 2022Hydatidiform mole (HM) is an abnormal human pregnancy characterized by excessive growth of placental trophoblasts and abnormal early embryonic development.
R. Slim+8 more
semanticscholar +1 more source
A Novel Mutation in NLRP7 Related to Recurrent Hydatidiform Mole and Reproductive Failure
International Journal of Fertility and Sterility, 2019Background Hydatidiform mole (HM) is an abnormal human pregnancy with excessive trophoblastic proliferation and abnormal embryonic development, dividing into two complete HM (CHM) and partial HM (PHM) groups.
Jafar Fallahi+6 more
semanticscholar +1 more source
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2010
Hydatidiform moles (HMs) are abnormal conceptions of excessive trophoblast development resulting in abnormal human pregnancies with no embryo and cystic degeneration of the chorionic villi. Prompt diagnosis, treatment and follow-up of patients using assays for betahCG from centres that specialise in this condition enable early diagnosis of potential ...
Denise Williams+2 more
openaire +2 more sources
Hydatidiform moles (HMs) are abnormal conceptions of excessive trophoblast development resulting in abnormal human pregnancies with no embryo and cystic degeneration of the chorionic villi. Prompt diagnosis, treatment and follow-up of patients using assays for betahCG from centres that specialise in this condition enable early diagnosis of potential ...
Denise Williams+2 more
openaire +2 more sources
Immunogenicity of hydatidiform mole☆
Placenta, 1987The HLA and ABO systems were studied in patients with complete hydatidiform mole (CHM). The study confirmed that CHM can immunize the patient against paternally derived HLA-ABC antigens. In patients who required subsequent treatment for trophoblastic tumours the frequency of antibody detection was much higher (10/14) at the time of treatment than it ...
Rosemary A. Fisher, Sylvia D. Lawler
openaire +3 more sources